
Lantheus Holdings LNTH
€ 57.35
0.99%
Quartalsbericht 2025-Q3
hinzugefügt 06.11.2025
Lantheus Holdings EV 2011-2025 | LNTH
EV Jährlich Lantheus Holdings
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.44 B | 4.54 B | 5.27 B | 3.53 B | 1.29 B | 898 M | 890 M | 1.17 B | 593 M | 452 M | 469 M | 478 M | 498 M | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 6.44 B | 452 M | 2.04 B |
EV anderer Aktien in der Diagnostik & Forschung
| Name | EV | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Brainsway Ltd.
BWAY
|
223 M | $ 16.64 | -1.25 % | $ 99.4 M | ||
|
Centogene N.V.
CNTG
|
-19.1 M | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
1.64 B | - | -17.87 % | $ 25.9 M | ||
|
DarioHealth Corp.
DRIO
|
6.61 M | $ 11.98 | 0.76 % | $ 340 M | ||
|
DexCom
DXCM
|
52.4 B | $ 66.7 | -0.39 % | $ 25.7 B | ||
|
Burning Rock Biotech Limited
BNR
|
433 M | $ 16.71 | 6.1 % | $ 180 M | ||
|
Exact Sciences Corporation
EXAS
|
12.2 B | $ 101.53 | 0.03 % | $ 18.8 B | ||
|
Accelerate Diagnostics
AXDX
|
92.6 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
15 M | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
35.7 M | $ 1.59 | -1.91 % | $ 2.02 M | ||
|
IQVIA Holdings
IQV
|
54.8 B | $ 222.65 | 0.18 % | $ 40.4 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
26.2 M | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
665 M | $ 38.47 | -0.41 % | $ 1.07 B | ||
|
Chembio Diagnostics
CEMI
|
39.2 M | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
150 B | $ 226.5 | 0.08 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
502 M | $ 26.81 | -1.22 % | $ 811 M | ||
|
Global Cord Blood Corporation
CO
|
-2.77 B | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
6.64 M | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
9.21 B | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
251 M | - | 0.12 % | $ 80.1 M | ||
|
Mettler-Toledo International
MTD
|
33.2 B | $ 1 415.66 | 1.58 % | $ 30 B | ||
|
DermTech
DMTK
|
70.4 M | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
5.02 B | - | - | $ 10.7 B | ||
|
Myriad Genetics
MYGN
|
1.2 B | $ 7.01 | -2.77 % | $ 635 M | ||
|
NeoGenomics
NEO
|
1.9 B | $ 12.08 | 1.94 % | $ 1.53 B | ||
|
Neogen Corporation
NEOG
|
2.26 B | $ 6.83 | -0.51 % | $ 1.48 B | ||
|
CareDx, Inc
CDNA
|
644 M | $ 19.96 | -2.92 % | $ 1.07 B | ||
|
Celcuity
CELC
|
506 M | $ 102.35 | -2.76 % | $ 4.04 B | ||
|
Enzo Biochem
ENZ
|
-22.7 M | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
1.5 M | $ 3.56 | -0.7 % | $ 114 K | ||
|
Co-Diagnostics
CODX
|
29.3 M | $ 0.31 | -9.02 % | $ 9.1 M | ||
|
Pacific Biosciences of California
PACB
|
2.28 B | $ 2.11 | -0.71 % | $ 535 M | ||
|
Quidel Corporation
QDEL
|
460 M | $ 28.87 | 0.24 % | $ 1.22 B | ||
|
Koninklijke Philips N.V.
PHG
|
14.5 B | $ 26.56 | -0.23 % | $ 20 B | ||
|
Guardant Health
GH
|
6.94 B | $ 104.86 | 2.73 % | $ 12.9 B | ||
|
Precipio
PRPO
|
10.9 M | $ 24.68 | -1.14 % | $ 32 M | ||
|
QIAGEN N.V.
QGEN
|
11.3 B | $ 45.24 | 0.04 % | $ 10.1 B | ||
|
Aspira Women's Health
AWH
|
42.8 M | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
5.87 B | $ 16.81 | -0.15 % | $ 4.75 B | ||
|
Heska Corporation
HSKA
|
851 M | - | - | $ 1.31 B | ||
|
Soleno Therapeutics
SLNO
|
1.95 B | $ 51.43 | -1.1 % | $ 2.07 B | ||
|
HTG Molecular Diagnostics
HTGM
|
3.16 M | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
15.3 B | $ 134.29 | -0.43 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
12.4 B | $ 196.55 | 1.82 % | $ 10.1 B | ||
|
Quotient Limited
QTNT
|
393 M | - | -11.32 % | $ 1.1 M | ||
|
Thermo Fisher Scientific
TMO
|
202 B | $ 567.34 | -0.76 % | $ 217 B | ||
|
Trinity Biotech plc
TRIB
|
133 M | $ 1.08 | 0.93 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
1.55 B | $ 31.12 | 0.61 % | $ 1.86 B | ||
|
Quest Diagnostics Incorporated
DGX
|
18.5 B | $ 183.54 | 0.54 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
142 M | $ 7.76 | -1.15 % | $ 1.01 B |